JPS5629591A - Tricyclic compound - Google Patents

Info

Publication number

JPS5629591A

JPS5629591A JP10481879A JP10481879A JPS5629591A JP S5629591 A JPS5629591 A JP S5629591A JP 10481879 A JP10481879 A JP 10481879A JP 10481879 A JP10481879 A JP 10481879A JP S5629591 A JPS5629591 A JP S5629591A

Authority

JP

Japan

Prior art keywords

formula

compound

lower alkyl

solvent

platelet

Prior art date

1979-08-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001875 compounds Chemical class 0.000 title abstract 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
• 208000007536 Thrombosis Diseases 0.000 abstract 2
• 125000000217 alkyl group Chemical group 0.000 abstract 2
• 239000002904 solvent Substances 0.000 abstract 2
• -1 1-Methyl-1,2,3,5-tetrahydroimidazo[1,2-a]quinazolin-2-one Chemical compound 0.000 abstract 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 abstract 1
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 1
• 239000002253 acid Substances 0.000 abstract 1
• 125000002947 alkylene group Chemical group 0.000 abstract 1
• 208000007502 anemia Diseases 0.000 abstract 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
• 230000003177 cardiotonic effect Effects 0.000 abstract 1
• 239000003054 catalyst Substances 0.000 abstract 1
• 239000003814 drug Substances 0.000 abstract 1
• 229910052736 halogen Inorganic materials 0.000 abstract 1
• 150000002367 halogens Chemical class 0.000 abstract 1
• 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
• 230000002401 inhibitory effect Effects 0.000 abstract 1
• 239000000463 material Substances 0.000 abstract 1
• 238000000034 method Methods 0.000 abstract 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
• 150000003839 salts Chemical class 0.000 abstract 1
• 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
• LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1

Cited By (2)